Maxim Chelushkin

3PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Iris Nederlof, Olga I Isaeva, Manon de Graaf

|Jul 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.

Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe

|Mar 30, 2024
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.

Nikita Kotlov, Kirill Shaposhnikov, Cagdas Tazearslan

Pageof 1

Frequent Collaborators

2 joint publications

Lodewyk F A Wessels

1 joint publications

Jeroen van Dorp

1 joint publications

Sandra van Wilpe

1 joint publications

Iris M Seignette